Psychotropic Medication and Diminishing Returns
Given the volume of e-mails I receive weekly, it is increasingly apparent to me that far too little information regarding the length of use of certain psychotropic medication classes is being transmitted from the prescriber to the patient. Length of use is important because inevitably, medication bites back. And when I say drugs bite back, I’m not referring to initial side effects – which are part and parcel of every medication ever to make it to market, to some extent. [...]